Bacterial Vaginosis Treatment Guidelines
Introduction to Bacterial Vaginosis Treatment
- The American College of Obstetricians and Gynecologists recommends oral metronidazole 500 mg twice daily for 7 days as the preferred treatment for bacterial vaginosis, with a high efficacy rate of 95% 1
- The Centers for Disease Control and Prevention suggests metronidazole gel 0.75%, one full applicator (5g) intravaginally once daily for 5 days as an alternative treatment with fewer systemic side effects 1
Bacterial Vaginosis Treatment Options
- The Centers for Disease Control and Prevention recommends metronidazole 2g orally in a single dose as an alternative treatment with lower efficacy (84% cure rate), but useful when compliance is a concern 2, 1
- Clindamycin 300 mg orally twice daily for 7 days is recommended by the Centers for Disease Control and Prevention as an alternative treatment 2, 1
Special Considerations for Bacterial Vaginosis Treatment
- For patients allergic to metronidazole, the Centers for Disease Control and Prevention recommends using clindamycin cream or oral clindamycin 2, 1
- Patients allergic to oral metronidazole should not use metronidazole vaginally, as recommended by the Centers for Disease Control and Prevention 2, 1
- The American College of Obstetricians and Gynecologists advises avoiding alcohol during metronidazole treatment and for 24 hours afterward due to potential disulfiram-like reaction 1
Trichomoniasis Treatment
- The Centers for Disease Control and Prevention recommends metronidazole 2g orally in a single dose as the treatment for trichomoniasis 3
- Treatment of sex partners is recommended by the Centers for Disease Control and Prevention to increase cure rates and reduce transmission 3
Mycoplasma genitalium and Mycoplasma hominis Treatment
- Clindamycin 300 mg orally twice daily for 7 days is often effective for Mycoplasma hominis, according to the American College of Obstetricians and Gynecologists 1
E. coli and Group B Streptococcus Treatment
- Appropriate antibiotics based on susceptibility testing are recommended by the American College of Obstetricians and Gynecologists for urogenital E. coli infections 1
- Penicillin or ampicillin are typically first-line treatments for Group B Streptococcus, as recommended by the American College of Obstetricians and Gynecologists 1
Treatment in Pregnancy
- All symptomatic pregnant women should be tested and treated for BV, according to the Centers for Disease Control and Prevention 2, 1
- The Centers for Disease Control and Prevention recommends metronidazole 250 mg orally three times daily for 7 days as the treatment for BV in pregnancy 2, 1
- Clindamycin 300 mg orally twice daily for 7 days is an alternative treatment for BV in pregnancy, as recommended by the Centers for Disease Control and Prevention 2
Follow-Up and Recurrence Management
- Follow-up visits are unnecessary if symptoms resolve, according to the Centers for Disease Control and Prevention 2, 1
- Routine treatment of male sex partners is not recommended for BV, as it has not been shown to influence a woman's response to therapy or reduce recurrence rates, as recommended by the Centers for Disease Control and Prevention 2, 1
Management of Sex Partners
- Treatment of sex partners is recommended by the Centers for Disease Control and Prevention for trichomoniasis 3
Clinical Pearls
- BV is associated with adverse pregnancy outcomes, including preterm delivery, according to the Centers for Disease Control and Prevention 2, 1
- Metronidazole gel is not effective for trichomoniasis, despite being effective for BV, as recommended by the Centers for Disease Control and Prevention 3
- Cytolytic vaginosis can mimic BV symptoms but requires different treatment, according to the American College of Obstetricians and Gynecologists 4
- Before surgical abortion or hysterectomy, screening and treating women with BV is recommended due to increased risk for postoperative infectious complications, as recommended by the American College of Obstetricians and Gynecologists 1
Treatment of Indeterminate Bacterial Vaginosis During Pregnancy
Treatment Recommendations
- The Centers for Disease Control and Prevention recommends metronidazole 250 mg orally three times daily for 7 days to reduce the risk of adverse pregnancy outcomes in pregnant women with indeterminate bacterial vaginosis 5
- For high-risk pregnant women, screening and treatment should be conducted at the earliest part of the second trimester, with a recommended regimen of metronidazole 250 mg orally three times daily for 7 days 5, 6
- Alternative regimens for high-risk pregnant women include metronidazole 2 g orally in a single dose 5, 6 and clindamycin 300 mg orally twice daily for 7 days 5, 6
Rationale for Treatment
- Bacterial vaginosis has been associated with adverse pregnancy outcomes, including premature rupture of membranes, preterm labor, and preterm birth, according to the Centers for Disease Control and Prevention 5, 6, 7
- Treatment of bacterial vaginosis in high-risk pregnant women who are asymptomatic may reduce the risk of preterm delivery 5, 8
Important Considerations
- Systemic therapy is preferred over topical therapy during pregnancy to treat possible subclinical upper genital tract infections, as recommended by the Centers for Disease Control and Prevention 6
- Clindamycin vaginal cream is not recommended during pregnancy due to increased risk of preterm deliveries in randomized trials 6, 7
- Patients should avoid alcohol during treatment with metronidazole and for 24 hours afterward, as advised by the Centers for Disease Control and Prevention 8
Safety of Metronidazole
- Multiple studies and meta-analyses have not demonstrated consistent associations between metronidazole use during pregnancy and teratogenic or mutagenic effects in newborns, according to the Centers for Disease Control and Prevention 5
- A meta-analysis does not indicate teratogenicity in humans, despite concerns about potential teratogenicity suggested by animal studies using extremely high doses 6, 9
CDC Recommendations for Management of Mycoplasma hominis in Pregnancy
Antibiotic Guidance
- The CDC MMWR Recommendations state that azithromycin treatment guidelines are intended for Mycoplasma genitalium and Chlamydia trachomatis infections and do not apply to M. hominis infections. 10, 11, 12
Contraindicated Antibiotics in Pregnancy
- The CDC MMWR Recommendations list doxycycline as contraindicated in pregnancy because of its teratogenic potential. 10, 11, 12
- The CDC MMWR Recommendations advise against the use of fluoroquinolones (e.g., moxifloxacin, ofloxacin, levofloxacin) in pregnant women due to fetal toxicity risk. 13
- The CDC MMWR Recommendations consider tetracyclines contraindicated throughout pregnancy. 13
Partner Management
- The CDC MMWR Recommendations recommend that sexual partners of pregnant women with M. hominis infection be evaluated and treated empirically. 10, 11, 12
- The CDC MMWR Recommendations advise abstaining from intercourse until both partners have completed a 7‑day antibiotic course. 10, 11, 12